Pot firm Aurora in $1bn buy deal

Canadian marijuana producer Aurora Cannabis has agreed to acquire CanniMed Therapeutics in a sweetened $1bn (€815m) cash-and-stock deal that would be the largest yet in the country’s red-hot cannabis industry.

Canadian marijuana producer Aurora Cannabis has agreed to acquire CanniMed Therapeutics in a sweetened $1bn (€815m) cash-and-stock deal that would be the largest yet in the country’s red-hot cannabis industry, writes Scott Deveau and Kristine Owram.

Investors will get 3.4 Aurora shares for each CanniMed share, or they can accept cash limited in aggregate to C$140m (91.6m), the companies said in a joint statement.